Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
S. Claiborne Johnston, Philippe Gabríel Steg, Basil S. Lewis, Wataru Shimizu et al.
Citations
25 citations
Journal
American Heart Journal
Topics
Atrial Fibrillation Management and Outcomes
Field-Weighted Citation Impact (FWCI)
10.05
article
Milvexian vs apixaban for stroke prevention in atrial fibrillation: The LIBREXIA atrial fibrillation trial rationale and design
S. Claiborne Johnston, Philippe Gabríel Steg, Basil S. Lewis, Wataru Shimizu, Jay Horrow, Karen S. Pieper, Graeme J. Hankey, Roxana Mehran, Stephen Weng, Christian T. Ruff, Jan H. Cornel, Sneha S. Jain, Kenneth W. Mahaffey, Julia Donahue, Robert A. Harrington, Danshi Li, Hooman Kamel, Carolyn S.P. Lam, Tatjana Potpara, John Strony, Jeffrey Ian Weitz, C. Michael Gibson, Alexei N. Plotnikov, Peter R. Kowey
article en
25 citations
Abstract
No abstract available for this paper.
Publication Tag
American Heart JournalVol. 277
Institutions
Brigham and Women's Hospital (US), Johnson & Johnson (United States) (US), Harvard University (US), Janssen (Belgium) (BE), Radboud University Nijmegen (NL), Thomas Jefferson University (US), National University of Singapore (SG), Technion – Israel Institute of Technology (IL), The University of Western Australia (AU), University of California, San Francisco (US), Lankenau Institute for Medical Research (US), Université Paris Cité (FR), Cornell University (US), Cardiovascular Institute of the South (US), University Medical Center (US), Radboud University Medical Center (NL), University of Belgrade (RS), Noordwest Ziekenhuisgroep (NL), Bristol-Myers Squibb (United States) (US), Assistance Publique – Hôpitaux de Paris (FR), MIND Research Institute (US), National University Heart Centre Singapore (SG), Baim Institute for Clinical Research (US), Centar za Promociju Nauke (RS), Carmel Medical Center (IL), Stanford Medicine (US), Thrombosis Research Institute (GB), Perron Institute for Neurological and Translational Science (AU), National Heart Centre Singapore (SG), Janssen (United States) (US), Center for Clinical Research (United States) (US), Nippon Medical School (JP), Stanford University (US), McMaster University (CA), Icahn School of Medicine at Mount Sinai (US)
Funders
Bristol-Myers Squibb, Janssen Research and Development